BAILEY O'DONNELL: Open Payments
NPI 1699309757 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 37 payments from 14 companies in 2025. Trend: 2023 $778 · 2024 $948 · 2025 $891
Food & beverage: $791Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $232 |
| Janssen Biotech, Inc. | 4 | $150 |
| ABBVIE INC. | 9 | $139 |
| UCB, Inc. | 3 | $82 |
| Lilly USA, LLC | 3 | $68 |
| Organon LLC | 3 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
| LEO Pharma Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Amgen Inc. | 1 | $23 |
Products named: Rhapsido, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, RINVOQ, EBGLYSS, VTAMA.
Industry payments across IA — which companies pay providers there.
